Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Uses of Chinese Herb as Adjuvants in Cancer Chemotherapy


Summary


One of the main reasons for failure in cancer chemotherapy is the selective growth of drug resistant cells during treatment. Agents that are non-toxic and can reverse this drug resistance is of great value to cancer chemotherapy. Rhizoma Alismatis, its extracts and fractions or chemicals isolated from the herb, were found to be able to reverse multidrug resistance in human cancer cells. The Rhizoma Alismatis preparations significantly increase the abilities of known cancer drugs to kill drug resistant cancer cells and a pharmacological synergism can be demonstrated when Rhizoma Alismatis preparations are mixed with a number of chemical cancer drugs.


Country/Region

Hong Kong

For more information, please click Here
Business of IP Asia Forum
Desktop View